Martina Flammer
Technik-/Wissenschafts-/F&E-Leiter bei INSMED INCORPORATED
Vermögen: 3 Mio $ am 30.04.2024
Profil
Martina Flammer is currently the Chief Medical Officer at Insmed, Inc. Prior to this, she worked at Boehringer Ingelheim International GmbH as SVP & Head-Corporate Division Customer Value from 2018 to 2019, and at Boehringer Ingelheim (Canada) Ltd.
as VP-Clinical Development & Medical Affairs from 2016 to 2018.
Before her corporate career, she earned a doctorate from the Medical University of Vienna and an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INSMED INCORPORATED
0,07% | 17.05.2024 | 106 134 ( 0,07% ) | 3 Mio $ | 30.04.2024 |
Aktive Positionen von Martina Flammer
| Unternehmen | Position | Beginn |
|---|---|---|
| INSMED INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 19.12.2019 |
Ehemalige bekannte Positionen von Martina Flammer
| Unternehmen | Position | Ende |
|---|---|---|
Boehringer Ingelheim International GmbH
 Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 |
Boehringer Ingelheim (Canada) Ltd.
 Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Ausbildung von Martina Flammer
| The Leonard N Stern School of Business | Masters Business Admin |
| Medical University of Vienna | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH BiotechnologyHealth Technology Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany. | Health Technology |
Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim (Canada) Ltd. BiotechnologyHealth Technology Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada. | Health Technology |
